| Title: |
513 Trial in progress: phase 1 first-in-human study of XL092 administered alone or in combination with immune checkpoint inhibitors in patients with inoperable locally advanced or metastatic solid tumors |
| Authors: |
Patnaik, Amita; Subbiah, Vivek; Shapiro, Geoffrey; Pal, Sumanta; Agarwal, Neeraj; Wentzel, Kristopher; Li, Jing; McIlvaine, Elizabeth; Waldes, Jana; Cha, Edward; Tadjalli-Mehr, Keyvan; Sharma, Manish |
| Source: |
Regular and Young Investigator Award Abstracts ; page A544-A544 |
| Publisher Information: |
BMJ Publishing Group Ltd |
| Publication Year: |
2021 |
| Document Type: |
conference object |
| Language: |
unknown |
| DOI: |
10.1136/jitc-2021-sitc2021.513 |
| DOI: |
10.1136/jitc-2021-SITC2021.513 |
| Availability: |
https://doi.org/10.1136/jitc-2021-sitc2021.513; https://syndication.highwire.org/content/doi/10.1136/jitc-2021-SITC2021.513 |
| Accession Number: |
edsbas.9714E218 |
| Database: |
BASE |